Literature DB >> 3917363

Psychosocial aspects of artificial feeding.

G V Padilla, M M Grant.   

Abstract

Artificial feeding can have an impact on the patient's quality of life. The psychosocial problems commonly reported in relation to parenteral nutrition are distress from loss of normal eating ability, depression, body image changes, fear of problems with apparatus, and decreased sexual activity. The psychosocial problems most commonly reported in relation to enteral nutrition include gustatory distress , some physical distress , and tube-related distress . Results of teaching approaches to reduce patient discomfort during tube feeding indicate that sensory rather than coping behavior information is more likely to be associated with higher levels of perceived control over enteral feeding, and that perceived control rather than perceived coping ability is more likely to be associated with willingness to repeat the experience. In general, the studies reviewed suggest that enteral feeding may be less stressful and produce fewer psychosocial problems than parenteral nutrition.

Entities:  

Mesh:

Year:  1985        PMID: 3917363     DOI: 10.1002/1097-0142(19850101)55:1+<301::aid-cncr2820551316>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  Quality of life of patients receiving home parenteral or enteral nutrition support.

Authors:  M Malone
Journal:  Pharmacoeconomics       Date:  1994-02       Impact factor: 4.981

Review 2.  Nutritional support in patients with oesophageal cancer.

Authors:  Federico Bozzetti
Journal:  Support Care Cancer       Date:  2009-06-24       Impact factor: 3.603

3.  Survey of Psychosocial Issues of Nasogastric Tube Feeding in Head-and-Neck Cancer Patients.

Authors:  Ravi Umrania; Dwija Patel; Bhavna C Patel; Manisha Singh; Priti Sanghavi; Himanshu Patel
Journal:  Indian J Palliat Care       Date:  2021-02-17

4.  Quality of life and home enteral tube feeding: a French prospective study in patients with head and neck or oesophageal cancer.

Authors:  C Roberge; M Tran; C Massoud; B Poirée; N Duval; E Damecour; D Frout; D Malvy; F Joly; P Lebailly; M Henry-Amar
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.